February 23, 2017
Valeant under magnifying glass of research reports coverage on healthcare stocks
Canada-based drugmaker Valeant Pharmaceuticals was put in focus for an online stock market analyist among several other healthcare companies. Valeant and EyeGate inked a deal for worldwide commercial and manufacturing rights to a product candidate for the treatment of post-operative pain and inflammation in ocular surgery patients.